L&G Pharma Breakthrough UCITS ETF (BIGT)
Category Sector Equity Biotechnology
This ETF can be held in an Investment ISA, SIPP and Investment Account
Sell
857.10p
Buy
861.20p
-13.40p (-1.54%)
Prices updated at 28 Feb 2025, 14:02 GMT
| Prices minimum 15 mins delay
Prices in GBX
Investment objective
The investment objective of the Fund is to provide exposure to bio-technology companies that are actively engaged in the research, development and/or manufacturing of orphan drugs. In order to achieve this investment objective, the Fund will seek to track the performance of the Solactive Pharma Breakthrough Value Index Net Total Return (the “Index”). It will do so by investing primarily in a portfolio of equity securities that, as far as possible and practicable, consists of the component securities of the Index in similar proportions to their weightings in the Index and may have exposure to or invest directly up to 20% of its Net Asset Value in shares issued by the same body, which limit may be raised to 35% for a single issuer in exceptional market conditions, including (but not limited to) circumstances in which such issuer occupies a dominant market position.
Important notice: This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Please refer to the FCA website which details further information in relation to sustainability disclosure requirements for retail clients.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Price
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk profile
- Management
Annual performance (%)
Year | This fund | Sector Equity Biotechnology |
---|---|---|
31 Dec 14 - 31 Dec 15 | - | - |
31 Dec 15 - 31 Dec 16 | - | - |
31 Dec 16 - 31 Dec 17 | - | - |
31 Dec 17 - 31 Dec 18 | - | - |
31 Dec 18 - 31 Dec 19 | 9.47 | 20.20 |
31 Dec 19 - 31 Dec 20 | 23.89 | 25.97 |
31 Dec 20 - 31 Dec 21 | -2.30 | -9.03 |
31 Dec 21 - 31 Dec 22 | 2.68 | -7.84 |
31 Dec 22 - 31 Dec 23 | -14.88 | -1.28 |
31 Dec 23 - 31 Dec 24 | -3.16 | -2.92 |
Morningstar category: Sector Equity Biotechnology
Trailing returns (%)
Year | This fund | Sector Equity Biotechnology |
---|---|---|
1 Day | 1.34 | 0.26 |
1 Month | 3.57 | -2.05 |
3 Months | 3.11 | -5.62 |
6 Months | 3.94 | -3.24 |
1 Year | 9.31 | -6.14 |
3 Years annualised | -0.09 | 4.24 |
5 Years annualised | 1.47 | 4.33 |
Morningstar category: Sector Equity Biotechnology
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.